These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Antibiotic resistance: development in surgical intensive care]. Weiss G; Tammer I; Wolff S Zentralbl Chir; 2011 Apr; 136(2):143-51. PubMed ID: 21351046 [TBL] [Abstract][Full Text] [Related]
3. [Antibiotics in the general practice]. Bogner J; Draenert R; Seybold U MMW Fortschr Med; 2016 Jun; 158(12):56-61; quiz 62-3. PubMed ID: 27324008 [No Abstract] [Full Text] [Related]
4. Drugs for bacterial infections. Treat Guidel Med Lett; 2010 Jun; 8(94):43-52. PubMed ID: 20489679 [No Abstract] [Full Text] [Related]
5. [Do we really need new antibiotics?]. Putensen C Dtsch Med Wochenschr; 2014 Nov; 139 Suppl 3():S83-4. PubMed ID: 25429536 [No Abstract] [Full Text] [Related]
6. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia. Jacobson LM; Milstone AM; Zenilman J; Carroll KC; Arav-Boger R Pediatr Infect Dis J; 2009 May; 28(5):445-7. PubMed ID: 19295462 [TBL] [Abstract][Full Text] [Related]
7. [Persistent bacteremia due to methicillin-resistant Staphylococcus aureus. A result of inadequate treatment]. Parra-Ruiz J; Tomas-Jiménez C; Muñoz-Medina L; Hernández-Quero J Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):372-3. PubMed ID: 19339080 [No Abstract] [Full Text] [Related]
14. Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistance. Stefani S; Goglio A Int J Infect Dis; 2010 Oct; 14 Suppl 4():S19-22. PubMed ID: 20843722 [TBL] [Abstract][Full Text] [Related]
15. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus. Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525 [TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus. Rehm SJ; Tice A Clin Infect Dis; 2010 Sep; 51 Suppl 2():S176-82. PubMed ID: 20731575 [TBL] [Abstract][Full Text] [Related]
17. Oral antibiotic treatment of MRSA infections. Cunha BA J Hosp Infect; 2005 May; 60(1):88-90. PubMed ID: 15823667 [No Abstract] [Full Text] [Related]
18. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. Sieradzki K; Roberts RB; Haber SW; Tomasz A N Engl J Med; 1999 Feb; 340(7):517-23. PubMed ID: 10021472 [No Abstract] [Full Text] [Related]
19. Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment. Liu WL; Hung YL; Lin SH; Lee PI; Hsueh PR Int J Antimicrob Agents; 2010 Jun; 35(6):615-6. PubMed ID: 20236804 [No Abstract] [Full Text] [Related]
20. Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia? Lalueza A; Chaves F; San Juan R; Daskalaki M; Otero JR; Aguado JM J Infect Dis; 2010 Jan; 201(2):311-2; author reply 312-3. PubMed ID: 20034343 [No Abstract] [Full Text] [Related] [Next] [New Search]